What is the intrinsic value of THQ?
As of 2025-05-18, the Intrinsic Value of Tekla Healthcare Opportunities Fund (THQ) is
31.89 USD. This THQ valuation is based on the model Peter Lynch Fair Value.
With the current market price of 18.20 USD, the upside of Tekla Healthcare Opportunities Fund is
75.24%.
Is THQ undervalued or overvalued?
Based on its market price of 18.20 USD and our intrinsic valuation, Tekla Healthcare Opportunities Fund (THQ) is undervalued by 75.24%.
31.89 USD
Intrinsic Value
THQ Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(16.22) - (10.40) |
(12.14) |
-166.7% |
| DCF (Growth 10y) |
(10.10) - (14.60) |
(11.46) |
-162.9% |
| DCF (EBITDA 5y) |
(6.08) - (5.83) |
(1,234.50) |
-123450.0% |
| DCF (EBITDA 10y) |
(6.79) - (6.46) |
(1,234.50) |
-123450.0% |
| Fair Value |
31.89 - 31.89 |
31.89 |
75.24% |
| P/E |
13.34 - 18.60 |
17.03 |
-6.4% |
| EV/EBITDA |
(6.47) - (6.81) |
(6.55) |
-136.0% |
| EPV |
(5.08) - (5.00) |
(5.04) |
-127.7% |
| DDM - Stable |
11.06 - 29.38 |
20.22 |
11.1% |
| DDM - Multi |
11.81 - 21.69 |
15.05 |
-17.3% |
THQ Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
753.12 |
| Beta |
3.55 |
| Outstanding shares (mil) |
41.38 |
| Enterprise Value (mil) |
978.12 |
| Market risk premium |
4.60% |
| Cost of Equity |
9.99% |
| Cost of Debt |
5.00% |
| WACC |
8.54% |